advertisement
Aspberg J 31
Showing records 1 to 25 | Display only abstracts from Aspberg J in IGR 22-2122141 The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field Development
Bengtsson B; Heijl A; Aspberg J; Aspberg J; Aspberg J; Jóhannesson G; Andersson-Geimer S; Andersson-Geimer S; Lindén C
American Journal of Ophthalmology 2024; 266: 274-288 (IGR: 25-1)
112787 Comparison of disease severity in glaucoma patients identified by screening in the 1990s and in routine clinical care in the 2010s in Sweden
Bengtsson B; Villalba C; Peters D; Aspberg J; Aspberg J; Aspberg J
Acta Ophthalmologica 2024; 102: 238-245 (IGR: 24-3)
109485 Long-term follow-up of laser trabeculoplasty in multi-treated glaucoma patients
Rasmuson E; Bengtsson B; Lindén C; Heijl A; Aspberg J; Aspberg J; Aspberg J; Andersson-Geimer S; Andersson-Geimer S; Jóhannesson G
Acta Ophthalmologica 2024; 102: 179-185 (IGR: 24-1/2)
106428 Estimating the Length of the Preclinical Detectable Phase for Open-Angle Glaucoma
Aspberg J; Aspberg J; Aspberg J; Heijl A; Bengtsson B
JAMA ophthalmology 2023; 141: 48-54 (IGR: 23-3)
104443 Threat to fixation and vision-related quality of life in early open-angle glaucoma - results from the Glaucoma Intensive Treatment Study
Peters D; Heijl A; Andersson-Geimer S; Andersson-Geimer S; Aspberg J; Aspberg J; Aspberg J; Lindén C; Jóhannesson G; Bengtsson B
Acta Ophthalmologica 2023; 101: 74-80 (IGR: 23-2)
94971 The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial
Bengtsson B; Lindén C; Heijl A; Andersson-Geimer S; Andersson-Geimer S; Aspberg J; Aspberg J; Aspberg J; Jóhannesson G
Acta Ophthalmologica 2022; 100: e455-e462 (IGR: 22-2)
92391 Screening for Open-Angle Glaucoma and Its Effect on Blindness
Aspberg J; Aspberg J; Aspberg J; Heijl A; Bengtsson B
American Journal of Ophthalmology 2021; 228: 106-116 (IGR: 22-1)
91593 Laser trabeculoplasty in newly diagnosed multi-treated glaucoma patients
Rasmuson E; Bengtsson B; Lindén C; Heijl A; Aspberg J; Aspberg J; Aspberg J; Andersson-Geimer S; Andersson-Geimer S; Jóhannesson G
Acta Ophthalmologica 2021; 99: 269-274 (IGR: 21-4)
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980 (IGR: 20-1)
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Lindén C
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980 (IGR: 20-1)
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Bengtsson B
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J; Heijl A
Journal of Glaucoma 2018; 27: 976-980 (IGR: 20-1)
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Heijl A
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Heijl A
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Jóhannesson G
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Johannesson G
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Jóhannesson G
Journal of Glaucoma 2018; 27: 976-980 (IGR: 20-1)
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Andersson-Geimer S
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Lindén C
Journal of Glaucoma 2018; 27: 976-980 (IGR: 20-1)
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Aspberg J
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Andersson-Geimer S
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Aspberg J; Aspberg J
Acta Ophthalmologica 2018; 96: 567-572 (IGR: 20-1)
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Aspberg J
Acta Ophthalmologica 2018; 96: 557-566 (IGR: 20-1)
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Andersson-Geimer S
Journal of Glaucoma 2018; 27: 976-980 (IGR: 20-1)